Tag : Product Development

Products With Purpose

Carlton Hoyt 11:26 am , March 13, 2012

Life science companies, and indeed companies in many industries, often get caught up in thinking about their products or services in terms of their features and benefits. Customers are often grouped by demographics. This type of thinking, however, often doesn’t lead to the best solutions for your customers needs.

There is a common saying that circulates among business and marketing aficionados (that I believe originated from a Harvard business professor) that no one wants a quarter inch drill – they want a quarter inch hole. If there was a tool to perform the task of making a quarter inch hole that was better suited to the job than a quarter inch drill, people would use it. Despite that, most companies selling drills focus their marketing on the drill, not the holes that the drill produces. When not focusing on the tool, many marketers focus on the customer or the market – trying to segment them into demographic baskets based on any of a wide number of criteria.

What doesn’t get the necessary amount of focus is the job that needs to be done. While life science companies actually do a better job of this than companies in many other industries, many life science marketers still lose sight of the purpose of the tool. No scientist has an inherent need for a thermal cycler. What the scientist needs is more copies of a genetic sequence. The thermal cycler manufacturer that will be positioned to have the highest ROI is the one that understands that and focuses on the job that needs to be done – amplification of DNA.

I won’t spend any more time on this topic because I don’t believe there is an epidemic lack of focus on the jobs that life science tools are meant to perform. However, there are many exceptions, and there have been many instances when a life science marketer or an entire company lost focus on the job that needed to be done and placed a highly disproportionate amount of focus on the product or the customer. Be sure you’re not the one that loses focus. Ask yourself on occasion what the jobs are that your products and services are being “hired” to perform. If you don’t have a solid answer, or if you’re not basing decisions on that answer, then it may be time to refocus.

"Is your product development not producing the blockbuster results that it should? Alternatively, do you have great products but your life science marketing just isn’t producing results? In both situations, BioBM is the solution. BioBM helps life science tool companies identify and validate marketplace needs, as well as develop and market solutions. When you’re ready to talk about ways to grow your business, contact us Our consultants are ready to help you succeed."

Product Lines: Breadth or Depth

Carlton Hoyt 9:25 am , February 1, 2012

Life science tools companies are constantly making important product development decisions, and almost all of these decisions involve making a tradeoff. Should your company focus its limited product development resources on entirely new lines, expansions to existing lines, or improvements to existing products? Much of this decision-making, especially for smaller companies, boils down to choosing between breadth and depth in the product portfolio. So what are the benefits of each, and when should each be given focus?

It’s certainly no easy question to answer generally. Without question much of the answer will depend on a company’s positioning and the opportunities that present themselves (a SWOT analysis is often good for helping to make such a determination), however there are many considerations that are less variable and can be discussed in a more general context. Let’s discuss a few of those.

Risk / Reward

To an extent, the 80/20 rule, or at the very least the rule of diminishing returns, comes into play in product development. A few key, highly differentiated products in any area are likely to make “80%” of your revenues in that area, assuming that you have such a product to begin with. Expanding on products in that area, or continuing to build on that key product through features, etc., will produce a far lesser return than did the development of the original product. Indeed, as more and more features are added to the key products, or more and more related products are added to the related product line, each improvement or addition will likely capture fewer and fewer customers. If the opportunity exists to build a disruptive product in another market, that will generally offer a much greater opportunity to build sales.

The risk of expanding into new markets, however, is much greater. Developing an entirely new product often involves the development or acquisition of new technology, and the cost is often much greater. It will involve markets that your company is less familiar with, and you may misjudge the market. Customers also gravitate towards holistic solutions, and if your offering doesn’t have the product support within your own line to stand alone, that may be viewed with significant negativity. Additionally, and this will lead us into the next point of discussion, if you don’t have a strong focus in any area then your company’s brand won’t be recognized as an authority in any area.

Having too narrow of a product line is a risk in and of itself as well. If you’re entirely invested in one market, and a competitor brings a highly disruptive technology into that market, you could be out of business. While building around a highly successful product line may be seen as risk-averse, small companies with limited product development resources still need to diversify to some extent.

Branding

If you have many great but unrelated ideas, continuously going after the “80%” may seem very tempting, but it does have its drawbacks. Not being known for any one area could have negative effects on your company’s brand. Especially if customers in a market have varied needs, you won’t be known as a go-to source for any of the types of products that you offer, even if you have that one standout product. If your product line is all over the place, having disparate, eclectic products with having a well-rounded offering for any particular need, customers won’t think to look to your company for anything, and that can certainly be problematic.

On the other hand, having a deep product line can help establish you in that area, again assuming your products are sufficiently differentiated. It also helps you focus brand-building marketing efforts, or at the very least makes them easier.

It’s worth repeating that there is no right answer or formula to follow that will tell you where you should focus your product development efforts. The decision must be dependent on your situation, risk tolerance, opportunities, and more. Align your company’s product development goals with your overall goals, carefully analyze your situation, and you’ll know what the right decision is.

"Are your product development efforts producing the results your life science company wants? Is your pipeline optimally aligned to deliver on future goals? Cut out the guesswork. Call BioBM Consulting and we’ll make sure your product development gives you the best opportunity to succeed."

Blog / Branding / Marketing Strategy 9:25 am , February 1, 2012

Success in Product Development

Carlton Hoyt 6:30 pm , May 2, 2011

Implementing and obeying go / kill criteria will ensure that your life science company has a better allocation of resources. For companies, success in life science product development does not mean completed development of a single product, or even successful commercialization of a product. Likewise, triage of one product development project does not equal failure. Successful product development lies in product development operations which best contribute to the success of the company. For any life science product development project, or for product development operations as a whole, projects must be evaluated for four key factors: value, strategy, balance, and resource availability.

Value is the most obvious factor by which to evaluate a product development project. There are many metrics by which to measure project value, such as net present value (NPV), expected commercial value (ECV), Productivity Index (PI) and a host of others. Our favorite metric is slightly different – We take the NPV of expected future profits, divide that by the NPV of project costs, then multiply by the probability of success. Note that for projects that are in progress, only future costs are considered. Money already spent can’t be recovered, so it is effectively irrelevant. Value, while very important, should not be the only thing considered. If your company is evaluating projects by value alone, you are likely making some poor decisions and not realizing it.

Strategy is crucially important in selecting life science product development projects. Companies must determine how the product will fit in with their greater strategic direction. A project that does not fit with the company’s strategy can shift focus away from more important areas, both within and outside of the context of product development.

Bioscience companies should also have a balanced portfolio of product development projects. Balance comes into play in many forms: long-term projects vs. short-term projects, projects with higher probabilities of success vs. those with higher potential returns, projects that are a close fit with corporate strategy vs. projects that are more loosely aligned, products that will protect markets vs. products that aim to expand the company’s market, etc. Too little product portfolio balance, either by too little diversity or too much, can increase risk.

Last but not least, life science product development must take into consideration resource allocation and availability. If an otherwise attractive project will hit a bottleneck because of insufficient resources, it may be more effective to begin another project first which better addresses current and projected resource availability.

In order to be successful, companies need to look at life science product development at a high level, ensuring that not only is each product right for the company, but all product development projects taken as a whole represent the best mix of projects for the company in terms of value, strategy, balance, and resource allocation. While many companies will rush to declare success based on individual projects, lasting success will come from a product development selection process that takes into account multiple factors and is geared to improve the company’s performance over a long term.

"Would you like more confidence that your company is undertaking the correct projects? Would you like to implement a system that will help you improve your bioscience product development pipeline? If the answer to either of those questions is yes, then look no further. BioBM’s experienced consultants have the product development and project management experience you need to bring more certainty and better decision making to your product development project selection processes. Contact us and we’ll get started."

Blog 6:30 pm , May 2, 2011

The Lost Art of Go / Kill

Carlton Hoyt 6:08 pm , April 12, 2011

Great ideas are precious things. They are the fuel driving innovation, the sustenance of progress, the energy that powers success. Not all great ideas are so great in practice, however. In the life sciences, as in all industries, ideas that are put into action need to be periodically re-evaluated to make sure they are working out to be as good as we thought they were. If they are not, then we would be best off scrapping them and focusing our energy and resources on something else … but life science companies seem to have a very hard time doing so, and this inability is to their detriment.

For your information...

Want to learn more about go / kill decision making? You can read about the stage-gate project management technique, from which go / kill is based, on Wikipedia.

The area where this lack of go / kill is most prominent and has the largest effects is product development. Life science product development projects have well-defined milestones and easily tracked metrics, yet go / kill criteria are usually nonexistent and when they are they are most often poorly defined and almost never strictly obeyed. Put simply, not having such criteria is a poor business practice and not obeying them is a poor business decision. Go / kill criteria are defined based on the risk at any point in time in comparison to the revenue potential. This information, which may be subjective but is still based on the best knowledge and information at the time the criteria is created, tells us whether we are likely to achieve our desired returns at any stage-gate (the point at the project when the go / kill decision is made) if we move forward with the project. If you are unlikely to achieve the desired returns, and resources would be better allocated elsewhere then the kill decision should be made, yet it very rarely is.

It is, to some extent, easy to understand why companies so infrequently utilize stage-gates successfully. Kill decisions are hard to make. In our business culture, killing a project is often interpreted as the project failing and this can cloud the business judgment of those on the team who do not want to appear to have been on a failed project. In practice, recognizing the need for a project kill and implementing it should be commendable, a gesture that the project team are willing to put the greater good of the company as a whole. Unfortunately, this rarely happens. No one ever handed out a “best project kill decision of the year” award. Kills are not seen as an achievement but project completion is, so most often projects push on even in the kind of adversity that makes desired returns extremely unlikely.

Other types of endeavors can benefit from stage-gate type go / kill decision making. For example, marketing campaigns can be periodically re-evaluated for ROI determination. If the ROI is not up to par, the campaign can be killed in favor of another which has a greater likelihood of success. Distributor / supplier relationships can be subjected to go / kill, and because of easily quantifiable metrics these decisions can be very easily gauged. Go / kill gates can even be easily and beneficially applied to the continuation of existing products. There are a multitude of other areas where life science companies can benefit from such gates as well.

Ensuring that resources are allocated to areas providing the greatest benefits is a cornerstone of a successful company. Ongoing projects and processes have a need to be periodically reevaluated to determine if they should be continued or “killed” in favor of other more promising endeavors. Despite this, life science companies rarely use go / kill decisions. Implementation of stage-gates and proper adherence to go / kill criteria will help life science companies ensure that that their resources are more optimally allocated and utilized.

"Does your life science company use stage-gates? Would you like to better implement go / kill criteria to improve your company’s resource allocation? Do you use go / kill criteria or stage-gating but find that it is poorly adhered to? BioBM’s team of business consultants can help you properly design and utilize go / kill criteria and implement staging to improve business results across a multitude of areas. If you would like to start improving your decision making, call or e-mail BioBM today."

Blog / Marketing Strategy 6:08 pm , April 12, 2011

Managing a Product Portfolio

Carlton Hoyt 7:21 pm , March 31, 2011

All companies making and / or selling life science tools and services have a product portfolio, but often these portfolios are not viewed in a strategic manner. While aligning current company competencies with current marketplace needs is a simple way to have successful products, a broader view of the product or service portfolio is necessary to ensure greater corporate, and long-term, success. In this post, I’ll go over some of the broader considerations of managing a product portfolio.

Note that many companies discuss product portfolio management to effectively be the new product development project selection process. While new product development project selection is an important part of product portfolio management, I believe this viewpoint to be too narrowly focused, as existing products need to be factored into portfolio management as well, and there are issues related to portfolio management that are indeed independent of new product development. I will discuss new product development project selection in more depth in a later post, as it is a critical business process, but for this post I will simply try to address some common questions relating more globally to product portfolio management in the life sciences.

How many products are the right amount?

Deciding how many products should be in your product portfolio is a difficult question, but there is a correct answer that requires balancing a multitude of factors. First of all, and arguably most importantly, is the amount of products that you can profitably develop. If you have the skills and the market need exists for more products, then building more is usually a good idea. Also important, however, are risk and the scope and goals of the company. If your product portfolio is too small or too narrow, then you may be exposing yourself to a large amount of risk by putting too many eggs in one basket, so to speak. On the other hand, if you have too many products you may lose focus of your scope and your goals, or simply lose the ability to effectively maintain or all of your product lines.

Should product X be in our product portfolio?

Again, if you have the skills to build a given product and the market need exists for it, then it is usually a good idea to build it. Before diving in head first, however, be sure you know the opportunities and threats of doing so. Also, if a given product is sufficiently outside the rest of your product portfolio, then other problems may arise. Your customers not view you as having a competency in that area and this can hurt customer confidence in that particular product or product line, adversely affecting sales. Furthermore, a disparate product from others in your portfolio may incur large marketing cots, as the effective economies of scale achieved by co-marketing (effectively marketing for many products at once) may not exist. For older products, you periodically need to ask if the product is still worth supporting. This should not be a simple question of if the product is obsolete, however, but rather will the profits from making or selling the product meet the desired rate of return. Ultimately, strategy and rate of return are the most important deciding factors in deciding if a product should be developed, maintained, or scrapped.

How do I know my product portfolio has the right mix of products?

Your developed product portfolio should accurately reflect your core competencies and the current needs of the life science research market while your product development projects should be addressing anticipated future needs. Make good use of market research to figure out exactly what those needs are with respect to your business.

Notes for life science distribution companies

If you’re a life science distribution company your job of product portfolio management is in many ways much simpler since you have no product development costs. However, there are still costs associated with bringing on a new product or product line, so having as large an offering as possible is often not a good strategy. Also, consider your strategic positioning within the life science marketplace and align your product offerings to that positioning. If your strategy involves certain segments of the life science market, leverage your product portfolio to gain a reputation as an expert “go-to” seller within that market segment. Since you have less variables to deal with than manufacturers, fully-quantitative, even automated, processes for dealing with portfolio management processes are also sometimes possible.

Effectively managing your product portfolio will not only ensure that your business is profitable in the short- and mid-term, but by aligning with strategies and goals can help lead your bioscience company to long-term success.

"Are you concerned that your product portfolio is too large or too small? Want to leverage your product portfolio to mitigate risk while simultaneously increasing revenues? Would you like to know what your product portfolio should look like in the future so you can make more informed decisions regarding product development projects? BioBM’s seasoned business consultants can analyze your product portfolio and help guide your bio-tools or life science services business to a more successful future. Give us a call or send us an e-mail and we’ll discuss your goals and how you can develop and leverage a winning product portfolio to achieve them."

Blog / Marketing Strategy 7:21 pm , March 31, 2011

Driving Innovation

Carlton Hoyt 5:54 pm , March 7, 2011

Innovation is key to success is biotechnology and the life sciences. What was once “out-of-the-box” is no longer out of the box. As time goes on and progress is made, your company must continuously progress in order to remain competitive. In essence, those companies that can enact positive change faster than the rest will, over time, become more successful, and a key component of positive change is innovation. Knowing how to change and fostering innovation are complex and abstract challenges, and many biotechnology companies have difficulty dealing with them. The challenge of driving innovation, which I will discuss in this post, can be tackled with some creative thinking and by fostering a suitable environment.

Before I get into the “how”, I’d like to offer another important piece of advice. Innovation in many companies is something that is performed reactively. Most companies, especially those beyond the start-up phase, innovate in response to a pressing business need. Innovating in this manner will allow your company to adapt, but rarely will it allow you to excel. In order to start being a leader in your field, you need to innovate proactively. Make it a point to account for innovation in your company’s goals and strategy to help ensure innovation stays proactive.

Innovation more frequently occurs at interfaces where different ideas and perspectives come together, so encourage that within your company. Do your engineers and scientists not frequently talk? Make sure they have an opportunity to get together and talk about product development and your current products and technologies. Mix in personnel from marketing, sales, and support as well since these are the people who communicate most with customers and will be most in tune to their needs. It isn’t enough to just have them generate ideas, however – there needs to be an avenue for these ideas to be vetted and potentially obtain buy-in from the appropriate people in management. Make sure that avenue exists and is communicated to your employees so you can allow innovation to come from all areas within your company. It is also worth noting that a Gallup study found that the most engaged employees are the most likely to be driving innovation, so if you are thinking of creating focus groups or using other inclusive techniques to foster innovation, you may want to select the most engaged employees.

Innovation can come from outside your company as well. Another great benefit to having broad connections with customers (which can be fostered via customer relationship management, social media marketing, directly, etc.) is leveraging them for ideas on how to improve your products. While your customers will be unlikely to drop the next great technological breakthrough in your lap, they are often very happy to tell you what they need. If you have a particular problem that you need solved, you can use “challenges” with high-value prizes to get ideas. Such challenges themselves, however, require a solid marketing effort to ensure that they are well received and that your company gets a good enough response to make it likely that at least one submission will meet your needs. Alternatively, you can leverage existing platforms that post innovation challenges such as Nature and InnoCentive’s Open Innovation Pavilion.

All companies must change and innovate to grow and stay competitive, and the ability to successfully innovate is of immense value to life science corporations. While harnessing the power of something as abstract as innovation can be difficult, building goals, strategies and tasks with innovation in mind can being the process more within reach and under control. Once your company starts reliably driving innovation, you can proactively change to become a leader in your field.

"Is your company suffering from a lack of creativity? Need to kick-start innovation at your company to move forward product development or address difficult business or marketing issues? Every consultant at BioBM is an expert innovator (literally – at the time of writing every consultant at BioBM has conceptualized / developed a new product), and our Business team can help you build innovation into your company. Call or e-mail us to discuss how we can help your company drive innovation and become a leader in your field."

Blog 5:54 pm , March 7, 2011